• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血流导向装置置入术后即刻急性内漏:早期发现和处理的标准观察时间的风险因素和相关性。

Acute Intraprocedural Thrombosis After Flow Diverter Stent Implantation: Risk Factors and Relevance of Standard Observation Time for Early Detection and Management.

机构信息

Department of Neuroradiology, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

Department of Neurology, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

出版信息

Clin Neuroradiol. 2023 Jun;33(2):343-351. doi: 10.1007/s00062-022-01214-6. Epub 2022 Sep 6.

DOI:10.1007/s00062-022-01214-6
PMID:36068407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10219871/
Abstract

PURPOSE

Acute intraprocedural thrombosis (AIT) is a severe complication of flow diverter stent (FDS) implantation for the treatment of intracranial aneurysms. Even though device-related thromboembolic complications are well known, there are no acknowledged risk factors nor defined surveillance protocols for their early detection. This study aimed to demonstrate that an angiographic active surveillance is effective to detect and treat AIT. Furthermore, we investigated risk factors for the occurrence of AIT.

METHODS

A prospective institutional protocol consisting of a defined observation period of 30 min following FDS deployment was established to detect AIT. Overall incidence, as well as the efficacy and safety of AIT treatment were assessed. Moreover, radiological and clinical outcomes of patients with AIT were analyzed. The influence of various patient- and procedure-related factors on the occurrence of AIT was investigated using multivariable forward logistic regression.

RESULTS

During active surveillance twelve cases of AIT were observed among a total of 161 procedures (incidence: 7.5%). The median time of first observation was 15.5 min (IQR 9.5) after FDS implantation. The early recognition of AIT ensured a prompt treatment with intravenous application of a glycoprotein IIb/IIIa inhibitor, which led to complete thrombus resolution in all cases without hemorrhagic complications. Patients with pre-existing arterial hypertension and side branches originating from the aneurysmal sac had a higher risk of AIT (respectively OR, 9.844; OR, 3.553). There were two cases of re-thrombosis in the short-term postoperative period, of whom one died. The remaining patients with AIT had a good clinical outcome.

CONCLUSION

Active surveillance for 30 min after FDS implantation is an effective strategy for early detection and ensuing treatment of AIT and can thus prevent secondary sequalae. Hypertension and side branches originating from the aneurysmal sac may increase the risk of AIT.

摘要

目的

急性术中血栓形成(AIT)是血流导向支架(FDS)植入治疗颅内动脉瘤的严重并发症。尽管器械相关的血栓栓塞并发症众所周知,但对于其早期检测尚无公认的危险因素或明确的监测方案。本研究旨在证明血管造影主动监测可有效检测和治疗 AIT。此外,我们还研究了 AIT 发生的危险因素。

方法

建立了一项前瞻性的机构方案,在 FDS 植入后设定了 30 分钟的明确观察期,以检测 AIT。评估了 AIT 的总发生率、疗效和安全性。此外,还分析了 AIT 患者的放射学和临床结局。使用多变量向前逻辑回归研究了各种患者和手术相关因素对 AIT 发生的影响。

结果

在主动监测期间,在总共 161 例手术中观察到 12 例 AIT(发生率:7.5%)。首次观察的中位数时间为 FDS 植入后 15.5 分钟(IQR 9.5)。早期识别 AIT 确保了及时应用糖蛋白 IIb/IIIa 抑制剂进行治疗,所有病例的血栓均完全溶解,无出血并发症。患有先前存在的动脉高血压和起源于动脉瘤囊的侧支的患者 AIT 风险较高(分别 OR,9.844;OR,3.553)。术后短期内有 2 例再血栓形成,其中 1 例死亡。其余 AIT 患者的临床结局良好。

结论

在 FDS 植入后 30 分钟进行主动监测是早期发现和随后治疗 AIT 的有效策略,可预防继发性后遗症。高血压和起源于动脉瘤囊的侧支可能会增加 AIT 的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8780/10219871/3e2fe93aa1a8/62_2022_1214_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8780/10219871/226fda6276a2/62_2022_1214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8780/10219871/3e2fe93aa1a8/62_2022_1214_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8780/10219871/226fda6276a2/62_2022_1214_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8780/10219871/3e2fe93aa1a8/62_2022_1214_Fig2_HTML.jpg

相似文献

1
Acute Intraprocedural Thrombosis After Flow Diverter Stent Implantation: Risk Factors and Relevance of Standard Observation Time for Early Detection and Management.血流导向装置置入术后即刻急性内漏:早期发现和处理的标准观察时间的风险因素和相关性。
Clin Neuroradiol. 2023 Jun;33(2):343-351. doi: 10.1007/s00062-022-01214-6. Epub 2022 Sep 6.
2
Early angiographic signs of acute thrombus formation following cerebral aneurysm treatment with the Pipeline embolization device.使用Pipeline栓塞装置治疗脑动脉瘤后急性血栓形成的早期血管造影征象。
J Neurointerv Surg. 2017 Nov;9(11):1125-1130. doi: 10.1136/neurintsurg-2016-012701. Epub 2016 Oct 21.
3
Flow-diverter stent to manage intracranial aneurysms: A single center experience.血流导向支架治疗颅内动脉瘤:单中心经验
J Chin Med Assoc. 2022 Mar 1;85(3):358-363. doi: 10.1097/JCMA.0000000000000619.
4
Treatment of Distal Anterior Cerebral Artery Aneurysms with Flow-Diverter Stents: A Single-Center Experience.血流导向装置治疗大脑前动脉远端动脉瘤:单中心经验。
AJNR Am J Neuroradiol. 2018 Jun;39(6):1100-1106. doi: 10.3174/ajnr.A5615. Epub 2018 Apr 12.
5
Postprocedural, midterm, and long-term results of cerebral aneurysms treated with flow-diverter devices: 7-year experience at a single center.血流导向装置治疗脑动脉瘤的术后、中期和长期结果:单中心7年经验
Neurosurg Focus. 2017 Jun;42(6):E3. doi: 10.3171/2017.3.FOCUS1732.
6
Early angiographic changes of intra-aneurysmal flow after flow-diverter stent treatment are not predictive of therapeutic success.血流导向支架治疗后动脉瘤内血流的早期血管造影改变不能预测治疗效果。
Interv Neuroradiol. 2016 Dec;22(6):682-686. doi: 10.1177/1591019916662192. Epub 2016 Aug 10.
7
Ischemic Stroke After Treatment of Intraprocedural Thrombosis During Stent-Assisted Coiling and Flow Diversion.支架辅助弹簧圈栓塞和血流导向治疗过程中发生术中血栓形成后的缺血性卒中
Stroke. 2017 Apr;48(4):1098-1100. doi: 10.1161/STROKEAHA.116.016521. Epub 2017 Feb 28.
8
Postprocedural Thrombosis following Endovascular Treatment of Intracranial Aneurysm with Flow Diverters or Coiling: A Histologic Study.血流导向装置或弹簧圈栓塞治疗颅内动脉瘤后血栓形成:组织学研究。
AJNR Am J Neuroradiol. 2022 Feb;43(2):258-264. doi: 10.3174/ajnr.A7369. Epub 2021 Dec 16.
9
A DSA-based method using contrast-motion estimation for the assessment of the intra-aneurysmal flow changes induced by flow-diverter stents.一种基于 DSA 的方法,使用对比运动估计来评估血流导向装置引起的瘤内血流变化。
AJNR Am J Neuroradiol. 2013 Apr;34(4):808-15. doi: 10.3174/ajnr.A3322. Epub 2012 Nov 1.
10
Recurrent reversible in-stent-stenosis after flow diverter treatment.血流导向装置治疗后反复出现的可复性支架内再狭窄。
Neuroradiology. 2023 Jul;65(7):1173-1177. doi: 10.1007/s00234-023-03144-7. Epub 2023 Mar 28.

引用本文的文献

1
Effectiveness of Flow Diverter Stents in the Treatment of Intracranial Aneurysms: Single-Center 10-Year Results.血流导向支架治疗颅内动脉瘤的有效性:单中心10年结果
Cureus. 2024 Nov 20;16(11):e74063. doi: 10.7759/cureus.74063. eCollection 2024 Nov.
2
Prasugrel Single Antiplatelet Therapy versus Aspirin and Clopidogrel Dual Antiplatelet Therapy for Flow Diverter Treatment for Cerebral Aneurysms: A Retrospective Multicenter Study.血流导向装置治疗颅内动脉瘤时普拉格雷单抗血小板治疗与阿司匹林和氯吡格雷双联抗血小板治疗的比较:一项回顾性多中心研究。
AJNR Am J Neuroradiol. 2024 May 9;45(5):592-598. doi: 10.3174/ajnr.A8163.
3
Long-term Follow-up After Aneurysm Treatment with the Flow Redirection Endoluminal Device (FRED) Flow Diverter.

本文引用的文献

1
Safety and efficacy results of the Flow Redirection Endoluminal Device (FRED) stent system in the treatment of intracranial aneurysms: US pivotal trial.血流导向腔内装置(FRED)支架系统治疗颅内动脉瘤的安全性和有效性结果:美国关键试验。
J Neurointerv Surg. 2022 Jun;14(6):577-584. doi: 10.1136/neurintsurg-2021-017469. Epub 2021 Jul 19.
2
Outcome of Flow Diverters with Surface Modifications in Treatment of Cerebral Aneurysms: Systematic Review and Meta-analysis.表面改性血流导向装置治疗颅内动脉瘤的结果:系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2021 Jan;42(2):327-333. doi: 10.3174/ajnr.A6919. Epub 2020 Dec 31.
3
血流导向装置(FRED)治疗动脉瘤的长期随访。
Clin Neuroradiol. 2024 Mar;34(1):181-188. doi: 10.1007/s00062-023-01346-3. Epub 2023 Oct 13.
Branch vessel occlusion in aneurysm treatment with flow diverter stent.
血流导向支架治疗动脉瘤时的分支血管闭塞。
Acta Biomed. 2020 Sep 23;91(10-S):e2020003. doi: 10.23750/abm.v91i10-S.10283.
4
Bailout Strategies and Complications Associated with the Use of Flow-Diverting Stents for Treating Intracranial Aneurysms.用于治疗颅内动脉瘤的血流导向支架的救助策略及相关并发症
Interv Neurol. 2020 Feb;8(1):38-54. doi: 10.1159/000489016. Epub 2018 Oct 16.
5
Value of CHA2DS2-VASc Score for Prediction and Ruling Out of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention.CHA2DS2-VASc 评分对经皮冠状动脉介入治疗后急性支架血栓形成的预测和排除价值。
Angiology. 2020 May;71(5):411-416. doi: 10.1177/0003319720903585. Epub 2020 Feb 7.
6
Mechanism of Action and Biology of Flow Diverters in the Treatment of Intracranial Aneurysms.血流导向装置治疗颅内动脉瘤的作用机制和生物学特性。
Neurosurgery. 2020 Jan 1;86(Suppl 1):S13-S19. doi: 10.1093/neuros/nyz324.
7
Thromboelastometry Shows Early Hypercoagulation in Patients with Spontaneous Subarachnoid Hemorrhage.血栓弹力描记术显示自发性蛛网膜下腔出血患者早期存在高凝状态。
World Neurosurg. 2019 Oct;130:e140-e149. doi: 10.1016/j.wneu.2019.06.019. Epub 2019 Jun 14.
8
Predictors of stent thrombosis and their implications for clinical practice.支架血栓形成的预测因素及其对临床实践的影响。
Nat Rev Cardiol. 2019 Apr;16(4):243-256. doi: 10.1038/s41569-018-0118-5.
9
Abciximab (ReoPro) Dosing Strategy for the Management of Acute Intraprocedural Thromboembolic Complications during Pipeline Flow Diversion Treatment of Intracranial Aneurysms.阿昔单抗(瑞替普酶)在颅内动脉瘤血流导向分流治疗中急性术中血栓栓塞并发症管理的给药策略。
Interv Neurol. 2018 Apr;7(5):218-232. doi: 10.1159/000486458. Epub 2018 Feb 27.
10
Safety and Efficacy of Flow Diverter Treatment for Aneurysm in Small Cerebral Vessels: A Systematic Review and Meta-Analysis.血流导向装置治疗小型颅内动脉瘤的安全性和有效性:系统评价和荟萃分析。
World Neurosurg. 2018 Jul;115:54-64. doi: 10.1016/j.wneu.2018.04.009. Epub 2018 Apr 10.